Nanobead-based interventions for the treatment and prevention of tuberculosis G Griffiths, B Nyström, SB Sable, GK Khuller Nature Reviews Microbiology 8 (11), 827-834, 2010 | 189 | 2010 |
Bacillus Calmette-Guerin vaccination using a microneedle patch Y Hiraishi, S Nandakumar, SO Choi, JW Lee, YC Kim, JE Posey, ... Vaccine 29 (14), 2626-2636, 2011 | 116 | 2011 |
Tuberculosis vaccine development: progress in clinical evaluation SB Sable, JE Posey, TJ Scriba Clinical microbiology reviews 33 (1), 10.1128/cmr. 00100-19, 2019 | 106 | 2019 |
An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection KA Birkness, J Guarner, SB Sable, RA Tripp, KL Kellar, J Bartlett, ... Immunology and cell biology 85 (2), 160-168, 2007 | 82 | 2007 |
Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin FB Sow, S Nandakumar, V Velu, KL Kellar, LS Schlesinger, RR Amara, ... Tuberculosis 91 (4), 314-321, 2011 | 78 | 2011 |
Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity SB Sable, M Kalra, I Verma, GK Khuller Clinical immunology 122 (3), 239-251, 2007 | 67 | 2007 |
Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis PK Giri, SB Sable, I Verma, GK Khuller FEMS Immunology & Medical Microbiology 45 (1), 87-93, 2005 | 63 | 2005 |
Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis SB Sable, I Verma, GK Khuller Vaccine 23 (32), 4175-4184, 2005 | 56 | 2005 |
Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models … SB Sable, R Kumar, M Kalra, I Verma, GK Khuller, K Dobos, JT Belisle Infection and immunity 73 (6), 3547-3558, 2005 | 55 | 2005 |
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice M Kalra, A Grover, N Mehta, J Singh, J Kaur, SB Sable, D Behera, ... Clinical Immunology 125 (2), 173-183, 2007 | 48 | 2007 |
O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection S Nandakumar, S Kannanganat, KM Dobos, M Lucas, JS Spencer, ... PLoS pathogens 9 (10), e1003705, 2013 | 43 | 2013 |
Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination SB Sable, M Cheruvu, S Nandakumar, S Sharma, K Bandyopadhyay, ... PLoS One 6 (7), e22718, 2011 | 43 | 2011 |
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice S Nandakumar, S Kannanganat, JE Posey, RR Amara, SB Sable PLoS One 9 (11), e113951, 2014 | 41 | 2014 |
Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins SB Sable, D Goyal, I Verma, D Behera, GK Khuller European Respiratory Journal 29 (2), 337-346, 2007 | 33 | 2007 |
Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens SB Sable, BB Plikaytis, TM Shinnick Vaccine 25 (9), 1553-1566, 2007 | 30 | 2007 |
Human immune recognition-based multicomponent subunit vaccines against tuberculosis SB Sable, I Verma, D Behera, GK Khuller European Respiratory Journal 25 (5), 902-910, 2005 | 28 | 2005 |
Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis S Nandakumar, S Kannanganat, KM Dobos, M Lucas, JS Spencer, ... Scientific reports 6 (1), 25837, 2016 | 27 | 2016 |
Polypeptide vaccine and vaccination strategy against mycobacterium S Sable, BB Plikaytis, TM Shinnick, RR Amara, M Cheruvu US Patent 8,741,313, 2014 | 25 | 2014 |
Polypeptide vaccine and vaccination strategy against mycobacterium S Sable, BB Plikaytis, TM Shinnick, RR Amara, M Cheruvu US Patent 8,741,313, 2014 | 25 | 2014 |
Immunodominance of low molecular weight secretory polypeptides of Mycobacterium tuberculosis to induce cytotoxic T-lymphocyte response SB Sable, S Kaur, I Verma, GK Khuller Vaccine 23 (41), 4947-4954, 2005 | 17 | 2005 |